Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | LTA4H | P09960 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | PGR | P06401 | 2/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SQSTM1 | Q13501 | 1/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28225549 | 0.86 | CA4 (0.59) | CA4LTA4HPKMCA1CA2 | |
| SCHEMBL25121932 | 0.84 | CA4 (0.56) | CA4LTA4HPKMCA1CA2 | |
| SCHEMBL22137255 | 0.82 | CA4 (0.54) | CA4LTA4HPKMCA1CA2 | |
| SCHEMBL7545245 | 0.82 | PKM (0.61) | CA4LTA4HPKMCA1CA2 | |
| SCHEMBL2900381 | 0.82 | PKM (0.83) | CA4LTA4HPKMCA1CA2 | |
| Anisole SCHEMBL29580625 | 0.79 | — | — | |
| 1,4-Dimethoxybenzene SCHEMBL27781098 | 0.79 | CA1 (0.85) | CA4LTA4HCA1CA2CA12 | |
| SCHEMBL8154133 | 0.79 | TSHR (0.64) | CA4PKMCA1CA2ALDH1A1 | |
| SCHEMBL22769563 | 0.79 | PKM (0.52) | CA4LTA4HPKMALDH1A1PGR | |
| Benzenesulfonamide SCHEMBL8827160 | 0.79 | PTGS2 (0.68) | CA4PKMCA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090294730-A1 | POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| EP-2039707-A1 | POLYMERIZABLE COMPOSITION | Adeka Corporation (JP) | 2009-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090294730-A1 | POLYMERIZABLE COMPOSITION | SCO2, NAT1, CORO1C | CA4 2788/4885LTA4H 3121/4885PKM 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.